Onset of pain relief with rofecoxib in chronic low back pain: results of two four-week, randomized, placebo-controlled trials.

Abstract:

OBJECTIVE:We recently reported the efficacy of rofecoxib in two randomized controlled trials in chronic low back pain (CLBP). The objectives of this report are to present data regarding the onset of efficacy of rofecoxib from these trials and propose methods for reporting onset. RESEARCH DESIGN AND METHODS:Patients were aged 18-75, with non-radicular CLBP for >or= 3 months. Patients were randomized to rofecoxib 25mg, 50 mg, or placebo once daily for 4 weeks. Assessments included Low Back Pain and Bothersomeness scales every morning and Relief from Starting Pain after the first dose at 0.5, 1, 2, 3, 4 h, bedtime, and next morning. Onset of meaningful relief was measured by Time to Confirmed 50% Reduction in Pain and Time to Confirmed 'Slightly' or 'Not At All' Bothersome Pain. Onset of perceptible pain relief was measured by Time to At Least 'A Little' Confirmed Pain Relief. RESULTS:690 patients entered. Significantly more patients treated with rofecoxib had compared with 1/3 receiving placebo. Median meaningful relief compared to placebo: 60.4, 58.4, and 34.7% for rofecoxib 25mg, 50 mg, and placebo (p< 0.001). Median time to meaningful relief for rofecoxib was 2 days, 1 day sooner than placebo. Rofecoxib was superior to placebo by bedtime after the first dose. CONCLUSIONS:Approximately 2/3 of patients achieved meaningful pain relief with rofecoxib time to onset of meaningful relief was about 2 days, but superior relief over placebo was seen by bedtime after the first dose. Onset of perceptible pain relief was within 2 h. We propose that measures of onset of analgesic effect include the proportion of patients who achieve meaningful pain relief and in this subgroup, the time-to-onset of confirmed meaningful reduction in pain intensity, time-to-onset of confirmed pain relief, and time to first separation from placebo in the proportion of patients who achieve meaningful pain relief.

journal_name

Curr Med Res Opin

authors

Katz N,Rodgers DB,Krupa D,Reicin A

doi

10.1185/030079904125003160

keywords:

subject

Has Abstract

pub_date

2004-05-01 00:00:00

pages

651-8

issue

5

eissn

0300-7995

issn

1473-4877

journal_volume

20

pub_type

临床试验,杂志文章,随机对照试验
  • Treat-to-target comparison between once daily biphasic insulin aspart 30 and insulin glargine in Chinese and Japanese insulin-naïve subjects with type 2 diabetes.

    abstract:OBJECTIVE:To investigate whether once daily biphasic insulin aspart 30 (BIAsp 30) is noninferior to once daily insulin glargine (IGlar) among Chinese and Japanese insulin-naïve subjects with type 2 diabetes mellitus (T2DM). RESEARCH DESIGN AND METHODS:This was a 24 week treat-to-target trial (NCT01123980) that include...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1185/03007995.2013.838155

    authors: Yang W,Xu X,Liu X,Yang G,Seino Y,Andersen H,Jinnouchi H

    更新日期:2013-12-01 00:00:00

  • First-year treatment costs among new initiators of topical prostaglandin analog identified from November 2007 through April 2008.

    abstract:OBJECTIVE:Ocular surface disease (OSD) is a common side effect of ophthalmic medications containing the preservative benzalkonium chloride (BAK). Little is known whether and how glaucoma treatment patterns and annual costs vary based on the presence of BAK. The objective of this analysis was to estimate first-year trea...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2010.531254

    authors: Schmier JK,Covert DW,Robin AL

    更新日期:2010-12-01 00:00:00

  • Therapeutic effects of hidrosmin on chronic venous insufficiency of the lower limbs.

    abstract::A double-blind, placebo-controlled trial was carried out to assess the effectiveness of a new synthetic bioflavonoid, hidrosmin, in patients with chronic venous insufficiency of the lower limbs. Fifty-seven patients, showing varicose veins and ankle swelling and suffering from local pain and heaviness of the legs, wer...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/03007999209111529

    authors: Domínguez C,Brautigam I,González E,González JA,Nazco J,Valiente R,Boada J

    更新日期:1992-01-01 00:00:00

  • Validation of a questionnaire to assess niacin-induced cutaneous flushing.

    abstract:BACKGROUND:Niacin is currently the most effective approved agent for raising high-density lipoprotein cholesterol. However, niacin-induced cutaneous flushing (redness, warmth, tingling and/or itching) significantly limits patient acceptance. To further characterize flushing, a patient-reported Flushing Symptom Question...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,随机对照试验

    doi:10.1185/030079907x199637

    authors: Norquist JM,Watson DJ,Yu Q,Paolini JF,McQuarrie K,Santanello NC

    更新日期:2007-07-01 00:00:00

  • Zuclopenthixol acetate (5% in 'Viscoleo'): single-dose treatment for acutely disturbed psychotic patients.

    abstract::Twenty-five acutely disturbed psychotic patients were treated in an open study with a single injection of zuclopenthixol acetate 5% in 'Viscoleo, a thin vegetable oil. Patients were assessed post-injection for 3 days using the BPRS, CGI, and a specially designed behaviour/activity scale. Doses of 50 to 150 mg proved e...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007999009111492

    authors: Chakravarti SK,Muthu A,Muthu PK,Naik P,Pinto RT

    更新日期:1990-01-01 00:00:00

  • The effects of orlistat in patients with diabetes: improvement in glycaemic control and weight loss.

    abstract:OBJECTIVE:In addition to direct weight reduction, there may be other benefits of obesity treatment including improved insulin sensitivity. The purpose of this study was to characterise concomitant diabetes drug use and the related costs in patients with diabetes treated with orlistat (Xenical) in the first 6 months of ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/030079905X74943

    authors: Rowe R,Cowx M,Poole C,McEwan P,Morgan C,Walker M

    更新日期:2005-11-01 00:00:00

  • A comparison of an antacid plus antispasmodic combination and aluminium hydroxide in dyspepsia.

    abstract::A single-blind, between-patient comparative study was carried out in general practice to assess the effectiveness of antacid plus antispasmodic combination tablets (240 mg dried aluminium hydroxide B.P., 144 mg magnesium hydroxide B.P.C., and 5 mg dicyclomine hydrochloride B.P.) and aluminium hydroxide B.P. tablets (5...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/03007997709110165

    authors: Kagan G,Rose R

    更新日期:1977-01-01 00:00:00

  • Targeting the pathophysiology of type 2 diabetes: rationale for combination therapy with pioglitazone and exenatide.

    abstract:OBJECTIVE:The objectives of this article are to review the pathophysiology of type 2 diabetes mellitus (T2DM), present the rationale for a pathophysiologically based treatment approach for patients with T2DM and discuss the role of the therapeutic combination of pioglitazone and exenatide in the management of T2DM. ME...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007990802390795

    authors: Schwartz S

    更新日期:2008-11-01 00:00:00

  • Long-term treatment with dantrolene sodium of stroke patients with spasticity limiting the return of function.

    abstract::A study was carried out to determine the efficacy and long-term safety of dantrolene in treating stroke patients with spasticity limiting rehabilitation. Fifteen of the 18 patients studied experienced reduction in spasticity and clinical improvement after treatment with dantrolene sodium for 6 weeks. Fourteen of these...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/03007998409109576

    authors: Ketel WB,Kolb ME

    更新日期:1984-01-01 00:00:00

  • Efficacy and safety of aceclofenac in the treatment of osteoarthritis: a randomized double-blind comparative clinical trial versus diclofenac - an Indian experience.

    abstract:OBJECTIVE:Osteoarthritis is one of the most common forms of arthritis seen in primary care. Non-steroidal anti-inflammatory drugs (NSAIDs) play an important role in the management of osteoarthritis. However, gastrointestinal (GI) side effects limit their use. Cyclooxygenase-2 (COX-2) selective inhibitors exhibit better...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,随机对照试验

    doi:10.1185/030079906X104722

    authors: Pareek A,Chandanwale AS,Oak J,Jain UK,Kapoor S

    更新日期:2006-05-01 00:00:00

  • Clinical effectiveness and radial artery remodeling assessment via very-high-frequency ultrasound/ultra biomicroscopy after applying slender 7Fr sheath for transradial approach in left main bifurcation disease.

    abstract:OBJECTIVE:To explore the clinical effect and radial remodeling of transradial slender 7 Fr sheath for left main bifurcation disease (LM bifurcation). METHODS:From January 2018 to September 2019, 236 patients with LM bifurcation undergoing transradial percutaneous coronary intervention (PCI) from two heart centers were...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2020.1815684

    authors: Xu Y,Li Y,Shen H,Zhang B,Zhao Q,Cheng Y,Zhao Z,Guo Q,Yang J,Zhou Y

    更新日期:2020-10-01 00:00:00

  • Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerability.

    abstract:OBJECTIVE:Short-term clinical trials have demonstrated the efficacy and safety of pregabalin in the treatment of generalized anxiety disorder (GAD). This study examined long-term safety and tolerability of pregabalin in patients with GAD, social anxiety disorder (SAD), or panic disorder (PD). RESEARCH DESIGN AND METHO...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1185/03007995.2013.820694

    authors: Montgomery S,Emir B,Haswell H,Prieto R

    更新日期:2013-10-01 00:00:00

  • Stratum corneum pharmacokinetics of the anti-fungal drug, terbinafine, in a novel topical formulation, for single-dose application in dermatophytoses.

    abstract:OBJECTIVE:The stratum corneum (SC) pharmacokinetics of terbinafine following single-dose administration of a novel cutaneous solution (film-forming solution, FFS) containing terbinafine hydrochloride and a film-forming agent, was investigated in three studies. Terbinafine 1% cream (Lamisil) was included as a benchmark ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,meta分析

    doi:10.1185/030079907X199664

    authors: Kienzler JL,Queille-Roussel C,Mugglestone C,Ortonne JP,Larnier C

    更新日期:2007-06-01 00:00:00

  • Efficacy and safety of local anesthetics bupivacaine, ropivacaine and levobupivacaine in combination with sufentanil in epidural anesthesia for labor and delivery: a meta-analysis.

    abstract:BACKGROUND:In epidural analgesia, synthetic opioids increase the potency of amide local anesthetics by modifying their analgesic properties. The purpose of this systematic review and meta-analysis is to compare the efficacy and safety of bupivacaine with ropivacaine and levobupivacaine in combination with sufentanil (B...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,meta分析,评审

    doi:10.1185/03007995.2014.946127

    authors: Lv BS,Wang W,Wang ZQ,Wang XW,Wang JH,Fang F,Mi WD

    更新日期:2014-11-01 00:00:00

  • The prevalence of anemia in patients with chronic kidney disease.

    abstract:OBJECTIVE:Anemia is a complication of chronic kidney disease and may contribute to adverse clinical outcomes. Early identification and treatment of anemia may improve cardiovascular morbidity and mortality. No large-scale population data are available specifically for patients with chronic kidney disease regarding prev...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,多中心研究

    doi:10.1185/030079904X2763

    authors: McClellan W,Aronoff SL,Bolton WK,Hood S,Lorber DL,Tang KL,Tse TF,Wasserman B,Leiserowitz M

    更新日期:2004-09-01 00:00:00

  • Lipid-lowering effects of colesevelam HCl in combination with ezetimibe.

    abstract:OBJECTIVE:The primary aim of this study was to compare the effect of colesevelam HCl in combination with ezetimibe to ezetimibe monotherapy on low-density lipoprotein cholesterol (LDL-C) levels in subjects with primary hypercholesterolemia. METHODS:Subjects with primary hypercholesterolemia (N = 86) were enrolled in a...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1185/030079906X148436

    authors: Bays H,Rhyne J,Abby S,Lai YL,Jones M

    更新日期:2006-11-01 00:00:00

  • Comparative effectiveness using a matching-adjusted indirect comparison between delayed-release dimethyl fumarate and fingolimod for the treatment of multiple sclerosis.

    abstract:OBJECTIVE:Delayed-release dimethyl fumarate (DMF; also known as gastro-resistant DMF) and fingolimod are approved oral disease-modifying treatments for relapsing-remitting multiple sclerosis. In phase 3 trials, DMF (DEFINE/CONFIRM) and fingolimod (FREEDOMS/FREEDOMS II) resulted in significant reductions in clinical and...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,meta分析

    doi:10.1080/03007995.2016.1248380

    authors: Fox RJ,Chan A,Zhang A,Xiao J,Levison D,Lewin JB,Edwards MR,Marantz JL

    更新日期:2017-02-01 00:00:00

  • Pulmonary oil micro-embolism (POME) syndrome: a review and summary of a large case series.

    abstract::The use of steroid compounds formulated in oil for depot injection can be associated with acute pulmonary reactions characterized primarily by cough, but sometimes with other associated symptoms. The pathophysiology of these reactions remains unclear, although they are reported in the literature as 'POMEs' or pulmonar...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007995.2015.1012254

    authors: Meyer RJ,Mann M

    更新日期:2015-04-01 00:00:00

  • Race, ethnicity, and use of thiazolidinediones among US adults with diabetes.

    abstract:OBJECTIVE:Significant race and ethnic disparities exist in diabetes-related health care. Using a nationally representative database, we sought to determine if use of thiazolidinediones (TZDs) differs by race and ethnicity. As a secondary objective, we sought to determine if race and ethnicity is associated with use of ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/030079906X167354

    authors: Aquilante CL,Zhang W,McCollum M

    更新日期:2007-03-01 00:00:00

  • Real-world evidence of the safety and efficacy profile of suvorexant in elderly patients with insomnia: a sub-analysis of the post-marketing drug-use results survey in Japan.

    abstract::Objective: Global Phase III trials of suvorexant showed no obvious differences in the safety and efficacy profile of suvorexant between elderly and non-elderly patients. However, the clinical profile of suvorexant in elderly patients with comorbidities in a real-world setting was not evaluated. To further understand t...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2019.1700361

    authors: Takeuchi Y,Sano H,Asai Y,Miyazaki M,Iwakura M,Maeda Y

    更新日期:2020-03-01 00:00:00

  • Exenatide BID Observational Study (ExOS): results for primary and secondary endpoints of a prospective research study to evaluate the clinical effectiveness of exenatide BID use in patients with type 2 diabetes in a real-world setting.

    abstract:OBJECTIVE:The Exenatide BID Observational Study (ExOS) was designed to evaluate the clinical effectiveness of exenatide BID use in patients with type 2 diabetes (T2D) in a real-world clinical practice setting in the United States. METHODS:Patients were enrolled from 74 practice sites from 9/2007 through 1/2009 and fol...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1185/03007995.2011.628305

    authors: Bergenstal RM,Garrison LP Jr,Miller LA,Hou L,Blickensderfer A,Zagar A,Stanley S,Bhargava A,Wade R,Herman WH

    更新日期:2011-12-01 00:00:00

  • The importance of calprotectin levels in obstructive sleep apnea syndrome severity.

    abstract:BACKGROUND:Obstructive sleep apnea syndrome (OSAS) is mostly seen in adult populations. It is known that increased levels of several inflammatory mediators play roles in OSAS and related comorbidities. Calprotectin is an inflammatory mediator that increases in some diseases such as Behçet's syndrome, bowel diseases and...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2017.1383890

    authors: Torun MT,Ünver E,Yalçın Y,Kanmaz L,Seçkin E

    更新日期:2018-03-01 00:00:00

  • Cost-effectiveness of statins in the prevention of coronary heart disease events in middle-aged Finnish men.

    abstract:OBJECTIVE:This study evaluated the long-term cost-effectiveness of atorvastatin 20 mg, rosuvastatin 10 mg and simvastatin 40 mg in primary and secondary prevention of CHD in Finland. RESEARCH DESIGN AND METHODS:The effect of statin therapy on the incidence of CHD and the expected total costs of the disease were descri...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007990802144705

    authors: Peura P,Martikainen J,Soini E,Hallinen T,Niskanen L

    更新日期:2008-06-01 00:00:00

  • 'Dos and don'ts' in the management of hyponatremia.

    abstract:INTRODUCTION AND OBJECTIVE:The management of hyponatremia has evolved in recent years, particularly with the introduction of tolvaptan for hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion (SIADH). This commentary presents a summary of recent international recommendations in the for...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2015.1072706

    authors: Aylwin S,Burst V,Peri A,Runkle I,Thatcher N

    更新日期:2015-01-01 00:00:00

  • Acarbose in addition to existing treatments in patients with type 2 diabetes: health economic analysis in a German setting.

    abstract:OBJECTIVE:A recent retrospective meta-analysis of cardiovascular events from long-term studies with acarbose in type 2 diabetes showed that treatment was associated with a significant reduction in the risk of cardiovascular events, supporting the hypothesis that postprandial hyperglycemia is a risk factor for cardiovas...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/030079906X115531

    authors: Roze S,Valentine WJ,Evers T,Palmer AJ

    更新日期:2006-07-01 00:00:00

  • A practice-based approach to the 2012 position statement of the American Diabetes Association and the European Association for the Study of Diabetes.

    abstract::The position statement on the management of hyperglycemia in patients with type 2 diabetes mellitus issued in 2012 by the American Diabetes Association and the European Association for the Study of Diabetes contains significant improvements over the 2009 version, including an emphasis on patient-centered care, enhance...

    journal_title:Current medical research and opinion

    pub_type: 评论,杂志文章

    doi:10.1185/03007995.2013.798637

    authors: Schwartz SS

    更新日期:2013-07-01 00:00:00

  • Achieving glycemic goal with initial versus sequential combination therapy using metformin and pioglitazone in type 2 diabetes mellitus.

    abstract:OBJECTIVE:To compare glycemic goal achievement (HbA(1c) < 7%) in type 2 diabetes patients receiving initial metformin plus pioglitazone combination therapy and initial metformin monotherapy augmented with pioglitazone in a cohort follow-up study. RESEARCH DESIGN AND METHODS:Adult patients were identified from the Inge...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2010.536755

    authors: Pandya BJ,Bron M,McCall T,Yu AP,Chen KS,Mattson ME,Wu EQ

    更新日期:2011-01-01 00:00:00

  • An examination of surgical and survival outcomes in the elderly (65-79 years of age) and the very elderly (≥80 years of age) who received surgery for gastric cancer.

    abstract::Objective: The purpose of this study was to examine surgical and survival outcomes in the elderly (65-79 years of age) and the very elderly (≥80 years of age) who received surgery for gastric cancer.Methods: This study retrospectively reviewed the records of patients ≥65 years old who received a gastrectomy for gastri...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2018.1520083

    authors: Wong JU,Tai FC,Huang CC

    更新日期:2020-02-01 00:00:00

  • Determinants of non-compliance with bisphosphonates in women with postmenopausal osteoporosis.

    abstract:OBJECTIVE:To identify determinants of non-compliance with bisphosphonates in women with postmenopausal osteoporosis. By considering the year of the introduction of weekly bisphosphonates important additional information is obtained. METHODS:New female users of daily or weekly alendronate or risedronate between 1999 an...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/030079908x297358

    authors: Penning-van Beest FJ,Erkens JA,Olson M,Herings RM

    更新日期:2008-05-01 00:00:00

  • Comparative analytical characterization of two commercial human follicle-stimulating hormones extracted from human urine.

    abstract:OBJECTIVE:Pharmaceutical preparations of human menopausal gonadotrophin (hMG), urine-derived follicle-stimulating hormone (u-FSH) and highly purified u-FSH (u-FSH-HP) have been available since the early 1960s and the mid 1980s and 1990s, respectively. Another commercial preparation of u-FSH-HP, Folyrmon P, was launched...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/030079905X48410

    authors: Bassett R,Ceccarelli D,Crisci C,di Tria AM,Mancinelli M,Martelli F,Mendola D,Pezzotti A

    更新日期:2005-06-01 00:00:00